Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-24-000087
Filing Date
2024-11-06
Accepted
2024-11-06 16:02:39
Documents
62
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20240930.htm   iXBRL 10-Q 997208
2 EX-31.1 a2024-q310xqex311.htm EX-31.1 10777
3 EX-31.2 a2024-q310xqex312.htm EX-31.2 10852
4 EX-32.1 a2024-q310xqex321.htm EX-32.1 4982
5 EX-32.2 a2024-q310xqex322.htm EX-32.2 4981
11 PIPELINE abus-20240930_g1.jpg GRAPHIC 42287
  Complete submission text file 0001447028-24-000087.txt   5410668

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20240930.xsd EX-101.SCH 38565
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20240930_cal.xml EX-101.CAL 43654
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20240930_def.xml EX-101.DEF 181926
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20240930_lab.xml EX-101.LAB 503846
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20240930_pre.xml EX-101.PRE 344623
64 EXTRACTED XBRL INSTANCE DOCUMENT abus-20240930_htm.xml XML 650230
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 241430806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)